Abstract
This study aimed to evaluate the efficacy of imidacloprid 10 %/moxidectin 2.5 % (w/v) spot-on (Advocate®/Advantage® Multi, Bayer) against adult Dirofilaria repens in a blinded, placebocontrolled randomised laboratory study. Twentyfour Beagle dogs were experimentally infected with approximately 75 infective D. repens larvae each on study day (SD) 0. Treatment was initiated on SD 228 after patency had been confirmed in 21 dogs, using a modified Knott Test. Eleven dogs received monthly treatments with imidacloprid/moxidectin at the minimum therapeutic dose (10 mg/kg imidacloprid and 2.5 mg/kg moxidectin) for six consecutive months and 12 control dogs were treated with a placebo formulation. Approximately one month after the last treatment, all dogs were euthanised and necropsied for the detection of D. repens worms. Eleven control dogs harboured live adult D. repens (range 2–11, geometric mean 5.44). Eight of 11 imidacloprid/moxidectin-treated dogs were free of live worms. The live worm count was reduced by 96.2 % (range 0–1, geometric mean 0.21). The majority of dead worms were encapsulated and degenerated. After the first treatment, Knott Tests were negative in all imidacloprid/moxidectin-treated dogs and this status was maintained in 10 dogs until study end. One dog showed a low microfilariae count (1 and 4/mL) on four occasions but was also negative before necropsy. The treatment was well tolerated by all study animals. It is concluded that six consecutive monthly treatments with imidacloprid/moxidectin spot-on are effective and safe against adult D. repens and provide an option for preventing the further spread of this zoonotic parasite.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
AHS: American Heartworm Society (2014) Current canine guidelines for the prevention, diagnosis and management of heartworm (Dirofilaria immitis) infection in dogs, revised July 2014. American Heartworm Society. http://www.heartwormsociety.org. Accessed 20 February 2015
Baneth G, Volansky Z, Anug Y, Favia G, Bain O, Goldstein RE, Harrus S (2002) Dirofilaria repens infection in a dog: diagnosis and treatment with melarsomine and doramectin. Vet Parasitol 105:173–178
Bowman DD, Mannella C (2011) Macrocyclic lactones and Dirofilaria immitis microfilariae. Top Companion Anim Med 26:160–172
Cancrini G, Tassi P, Coluzzi M (1989) Ivermectin against larval stages of Dirofilaria repens in dogs. Parassitologia 31:177–182
Conboy G, Hare J, Charles S, Settje T, Heine J (2009) Efficacy of a single topical application of Advantage Multi® (= Advocate®) topical solution (10 % Imidocloprid + 2.5 % Moxidectin) in the treatment of dogs experimentally infected with Crenosoma vulpis. Parasitol Res 105:S49–S54
Czajka C, Becker N, Jöst H, Poppert S, Schmidt-Chanasit J, Krüger A, Tannich E (2014) Stable transmission of Dirofilaria repens nematodes, northern Germany. Emerg Infect Dis 20:328–331
Di Cesare A, Braun G, Di Giulio E, Paoletti B, Aquilino V, Bartolini R, La Torre F, Meloni S, Drake J, Pandolfi F, Avolio S, Traversa D (2014) Field clinical study evaluating the efficacy and safety of an oral formulation containing milbemycin oxime/praziquantel (Milbemax®, Novartis Animal Health) in the chemoprevention of the zoonotic canine infection by Dirofilaria repens. Parasit Vectors. doi:10.1186/1756–3305–7–347
EMA (2009) Scientific discussion: Advocate. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Scientific_Discussion/veterinary/000076/WC500060915.pdf. Accessed 20 February 2015
Favia G, Cancrini G, Ricci I, Bazzocchi C, Magi M, Pietrobelli M, Genchi C, Bandi C (2000) 5 S ribosomal spacer sequences of some filarial parasites: comparative analysis and diagnostic applications. Mol Cell Probes 14:285–290
Fok E, Jacsó O, Szebeni Z, Gyorffy A, Sükösd L, Lukács Z, Schaper R (2010) Elimination of Dirofilaria (syn. Nochtiella) repens microfilariae in dogs with monthly treatments of moxidectin 2.5 %/imidacloprid 10 % (Advocate, Bayer) spoton. Parasitol Res 106:1141–1149
Genchi C, Genchi M, Petry G, Kruedewagen EM, Schaper R (2013) Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs. Parasitol Res 112(Suppl 1):81–89
Genchi C, Kramer LH, Rivasi F (2011) Dirofilarial infections in Europe. Vector Borne Zoonotic Dis 11:1307–1317
Genchi M, Pengo G, Genchi C (2010) Efficacy of moxidectin microsphere sustained release formulation for the prevention of subcutaneous filarial (Dirofilaria repens) infection in dogs. Vet Parasitol 170:167–169
Genchi C, Poglayen G, Kramer L, Casiraghi M, Venco L, Brianti E (2002) Efficacia di selamectin nella profilassi delle infestazioni da Dirofilaria repens del cane. Veterinaria 16:69–71
Giannelli A, Ramos RA, Traversa D, Brianti E, Annoscia G, Bastelli F, Dantas-Torres F, Otranto D (2013) Treatment of Dirofilaria repens microfilariaemia with a combination of doxycycline hyclate and ivermectin. Vet Parasitol 197:702–704
Hellmann K, Heine J, Braun G, Paran-Dobesova R, Svobodova V (2011) Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate®, Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens. Parasitol Res 109(Suppl 1):S77–86
Hermosilla C, Pantchev N, Dyachenko V, Gutmann M, Bauer C (2006) First autochthonous case of canine ocular Dirofilaria repens infection in Germany. Vet Rec 158:134–135
Jacobs DE, Arakawa A, Courtney CH, Gemmell MA, McCall JW, Myers GH, Vanparijs O (1994) World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of anthelmintics for dogs and cats. Vet Parasitol 52:179–202
Jacsó O, Fok E, Kiss G, Kökény G, Lang Z (2010) Preliminary findings on the efficacy of selamectin in the treatment of dogs naturally infected with Dirofilaria repens. Acta Vet Hung 58:405–412
Kramer L, Genchi C (2014) Where are we with Wolbachia and doxycycline: an in-depth review of the current state of our knowledge. Vet Parasitol 206:1–4
Kronefeld M, Kampen H, Sassnau R, Werner D (2014) Molecular detection of Dirofilaria immitis, Dirofilaria repens and Setaria tundra in mosquitoes from Germany. Parasit Vectors 7:30. doi:10.1186/1756-3305-7-30
Manfredi MT, Di Cerbo A, Genchi M (2007) Biology of filarial worms parasitizing dogs and cats. In: Genchi C, Rinaldi L, Cringoli G (ed) Mappe parassitologiche 8: Dirofilaria immitis and D. repens in dog and cat and human infections, 1st edn., Naples, pp. 41–45
Marconcini A, Magi M, Contin BH (1993) Efficacy of ivermectin in preventing Dirofilaria repens infestation in dogs naturally exposed to contagion. Parassitologia 35:67–71
McCall JW (2005) The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations. Vet Parasitol 133:197–206
McCall JW, Genchi C, Kramer LH, Guerrero J, Venco L (2008) Heartworm disease in animals and humans. Adv Parasitol 66:193–285
Pantchev N, Norden N, Lorentzen L, Rossi M, Rossi U, Brand B, Dyachenko V (2009) Current surveys on the prevalence and distribution of Dirofilaria spp. in dogs in Germany. Parasitol Res 105(Suppl 1):S63–74
Paran RD, Svobodová V (2011) Effect of therapy by using advocate spot-on combination (imidacloprid 10 % and moxidectin 2.5 %) on subcutaneous dirofilariosis in dogs. Vet Med Int. doi:10.4061/2011/482–746
Paterson TE, Halliwell RE, Fields PJ, Louw ML, Ball G, Louw J, Pinckney R (2014) Canine generalized demodicosis treated with varying dosesof a 2.5 % moxidectin + 10 % imidacloprid spot-on and oral ivermectin: Parasiticidal effects and long-term treatment outcomes. Vet Parasitol 205:687–696
Pollono F, Pollmeier M, Rossi L (1998) The prevention of Dirofilaria repens infection with ivermectin/pyrantel chewables. Parassitologia 40:457–459
Rishniw M, Barr SC, Simpson KW, Frongillo MF, Franz M, Dominguez Alpizar JL (2006) Discrimination between six species of canine microfilariae by a single polymerase chain reaction. Vet Parasitol 135:303–314
Rossi L, Ferroglio E, Agostini A (2002) Use of moxidectin tablets in the control of canine subcutaneous dirofilariosis. Vet Rec 150:383
Rossi L, Ferroglio E, Agostini A (2004) Use of an injectable, sustained release formulation of moxidectin to prevent canine subcutaneous dirofilariosis. Vet Rec 154:26–27
Sassnau R, Dyachenko V, Pantchev N, Stöckel F, Dittmar K, Daugschies A (2009) Dirofilaria repens Befall in einem Schlittenhunde-Rudel im Land Brandenburg, Diagnose und Therapie der kaninen kutanen Dirofilariose. Tieraerztl Praxis K 2:95–101
Simón F, Siles-Lucas M, Morchón R, González-Miguel J, Mellado I, Carretón E, Montoya-Alonso JA (2012) Human and animal dirofilariasis: the emergence of a zoonotic mosaic. Clin Microbiol Rev 25:507–544
Tappe D, Plauth M, Bauer T, Muntau B, Dießel L, Tannich E, Herrmann-Trost P (2014) A case of autochthonous human Dirofilaria infection, Germany, March 2014. Euro Surveill 19:2–4
Tasić-Otaševć SA, Trenkić Božinović MS, Gabrielli SV, Genchi C (2015) Canine and human Dirofilaria infections in the Balkan Peninsula. Vet Parasitol 209:151–156
Traversa D, Aste G, Di Cesare A, Paoletti B, Di Tommaso M, Di Giulio E, Pampurini F, Tunesi C, Boari A (2011) Efficacy of a single administration of a spot-on solution containing imidacloprid 10 % / moxidectin 2.5 % in eliminating Dirofilaria repens microfilariae in naturally infected dogs. Vet Parasitol 179:107–112
Traversa D, Mazzi A, Di Cesare A, Famigli Bergamini P, Fracassi F, Fanini G, Aste G, Pampurini F, Boari A (2013) Potential efficacy of monthly administrations of spot-on moxidectin 2.5 %/imidacloprid 10 % in the simultaneous prevention of major canine filarioses. Parasitol Res 112:3753–3756
Vanapalli SR, Hung YP, Fleckenstein L, Dzimianski MT, McCall JW (2002) Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs. Biopharm Drug Dispos 23:263–272
VICH Guideline 7: Efficacy of Anthelmintics: General Requirements. Veterinary International Cooperation on Harmonization, European Agency for the Evaluation of Medicinal Products, London, CVMP/VICH/832/99-corr, November 2000
VICH Guideline 9: Good Clinical Practice. Veterinary International Cooperation on Harmonization, European Agency for the Evaluation of Medicinal Products, London, CVMP/VICH/595/98-Final, June 2000
VICH Guideline 19: Efficacy of anthelmintics: Specific recommendations for canine. Veterinary International Cooperation on Harmonization, European Agency for the Evaluation of Medicinal Products, London, CVMP/VICH/835/99-Final, June 2001
Venco L, McCall JW, Guerrero J, Genchi C (2004) Efficacy of long-term monthly administration of ivermectin on the progress of naturally acquired heartworm infections in dogs. Vet Parasitol 124:259–268
Webber WA, Hawking F (1955) Experimental maintenance of Dirofilaria repens and D. immitis in dogs. Exp Parasitol 4:143–164
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Petry, G., Genchi, M., Schmidt, H. et al. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs. Parasitol Res 114 (Suppl 1), 131–144 (2015). https://doi.org/10.1007/s00436-015-4519-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-015-4519-7